Muir AJ - Search Results

1

Racial differences in hepatitis C treatment eligibility.

Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS; IDEAL Study Team. Melia MT, et al. Among authors: muir aj. Hepatology. 2011 Jul;54(1):70-8. doi: 10.1002/hep.24358. Hepatology. 2011. PMID: 21488082 Free PMC article.

2

Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients.

Patel K, Muir AJ, McHutchison JG. Patel K, et al. Among authors: muir aj. Hepatology. 2003 May;37(5):1222; author reply 1222-3. doi: 10.1053/jhep.2003.50159. Hepatology. 2003. PMID: 12717404 No abstract available.

3

A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats.

Patel K, Muir A, McHutchison JG, Patton HM. Patel K, et al. Am J Gastroenterol. 2003 May;98(5):952-5. doi: 10.1111/j.1572-0241.2003.07422.x. Am J Gastroenterol. 2003. PMID: 12809813 No abstract available.

4

Ribavirin as maintenance therapy for hepatitis C patients: an interim peacekeeper?

Patel K, Dev A, Muir AJ, McHutchison JG. Patel K, et al. Among authors: muir aj. Hepatology. 2003 Jul;38(1):21-4. doi: 10.1053/jhep.2003.50326. Hepatology. 2003. PMID: 12829982 Review. No abstract available.

5

Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin.

Balan V, Schwartz D, Wu GY, Muir AJ, Ghalib R, Jackson J, Keeffe EB, Rossaro L, Burnett A, Goon BL, Bowers PJ, Leitz GJ; HCV Natural History Study Group. Balan V, et al. Among authors: muir aj. Am J Gastroenterol. 2005 Feb;100(2):299-307. doi: 10.1111/j.1572-0241.2005.40757.x. Am J Gastroenterol. 2005. PMID: 15667486

6

Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection.

Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ. Condron SL, et al. Among authors: muir aj. Transplantation. 2005 Jul 15;80(1):145-8. doi: 10.1097/01.tp.0000164291.35925.7a. Transplantation. 2005. PMID: 16003247

7

Diagnosis and treatment of chronic hepatitis C infection.

Patel K, Muir AJ, McHutchison JG. Patel K, et al. Among authors: muir aj. BMJ. 2006 Apr 29;332(7548):1013-7. doi: 10.1136/bmj.332.7548.1013. BMJ. 2006. PMID: 16644828 Free PMC article. Review. No abstract available.

8

Growth factors during HCV therapy may be "cost-effective", but are they "effective"?

Muir AJ, McHutchison JG. Muir AJ, et al. Hepatology. 2006 Dec;44(6):1400-3. doi: 10.1002/hep.21426. Hepatology. 2006. PMID: 17133467 No abstract available.

9

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.

Lawitz E, Rodriguez-Torres M, Muir AJ, Kieffer TL, McNair L, Khunvichai A, McHutchison JG. Lawitz E, et al. Among authors: muir aj. J Hepatol. 2008 Aug;49(2):163-9. doi: 10.1016/j.jhep.2008.03.027. Epub 2008 Apr 29. J Hepatol. 2008. PMID: 18486984 Clinical Trial.

10

Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.

Nelson DR, Rustgi V, Balan V, Sulkowski MS, Davis GL, Muir AJ, Lambiase LR, Dickson RC, Weisner RH, Fiscella M, Cronin PW, Pulkstenis E, McHutchison JG, Subramanian GM. Nelson DR, et al. Among authors: muir aj. Clin Gastroenterol Hepatol. 2009 Feb;7(2):212-8. doi: 10.1016/j.cgh.2008.10.035. Epub 2008 Nov 7. Clin Gastroenterol Hepatol. 2009. PMID: 19061971 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters